KAZERA GLOBAL PLC

Regulatory Filings • Oct 4, 2022

National Storage Mechanism | Additional information

RNS Number : 6353B

Kazera Global PLC

04 October 2022

4 October 2022

Kazera Global plc

Align Research Coverage

Kazera Global plc ("Kazera Global", "Kazera" or "the Company"), the AIM quoted investment company, is pleased to announce that Align Research has today released research coverage on the Company.

Align Research have set a target price of 4.55p and reiterated their Conviction Buy stance. The note covers the potential of the tantalum and lithium mine to be unlocked, the production potential of Heavy Mineral Sands (HMS), the REE project acquisition, and risked conservative NPV suggesting upside of close to more than 500% among other analysis of the portfolio.

The research has been placed on the Company's website and can be found here:  http://www.alignresearch.co.uk/cpt-company/kazera-global/

For further information on the Company, visit:  www. kazeraglobal .com

Kazera Global plc (c/o Camarco) Dennis Edmonds (CEO)	Tel: +44 (0)203 757 4980
finnCap (Nominated Adviser and Joint Broker) Christopher Raggett / Tim Harper (Corporate Finance) Peterhouse Capital Limited (Joint Broker) Duncan Vasey / Lucy Williams (Corporate Broker)	Tel: +44 (0)207 220 0500 Tel: +44 (0) 207 220 9797
Camarco (PR) Gordon Poole / Elfie Kent / Hugo Liddy	Tel: +44 (0)20 3781 8331

**ENDS**

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAMJBPTMTIMBIT